4//SEC Filing
William Arsani 4
Accession 0001209191-22-020638
CIK 0001807120other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 7:28 PM ET
Size
7.3 KB
Accession
0001209191-22-020638
Insider Transaction Report
Form 4
William Arsani
Director
Transactions
- Purchase
Common Stock
2022-03-21$18.99/sh+25,000$474,680→ 2,797,501 total(indirect: By Logos Global Master Fund LP)
Holdings
- 1,217,627(indirect: By Logos Opportunities Fund II, L.P.)
Common Stock
- 2,032,501(indirect: By Logos SPV 1 LP)
Common Stock
Footnotes (2)
- [F1]The Reporting Person is a managing member of Logos Opportunities Fund II, L.P. and Logos SPV 1 LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]Logos Global Management LP ("LGM") is the investment adviser of private funds, including Logos Global Master Fund LP (the "Fund"). Logos GP LLC ("Fund GP") is the general partner of the Fund. The Reporting Person is the Manager of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001848372
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 7:28 PM ET
- Size
- 7.3 KB